TRILOGIQ (ALTRI.PA) Fundamental Analysis & Valuation

EPA:ALTRI • FR0010397901

Current stock price

4.98 EUR
+0.14 (+2.89%)
Last:

This ALTRI.PA fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

3

1. ALTRI.PA Profitability Analysis

1.1 Basic Checks

  • In the past year ALTRI has reported negative net income.
  • ALTRI had a positive operating cash flow in the past year.
  • In multiple years ALTRI reported negative net income over the last 5 years.
  • Of the past 5 years ALTRI 4 years had a positive operating cash flow.
ALTRI.PA Yearly Net Income VS EBIT VS OCF VS FCFALTRI.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2022 2023 2024 2025 0 2M -2M 4M -4M -6M -8M

1.2 Ratios

  • ALTRI has a worse Return On Assets (-1.02%) than 75.47% of its industry peers.
  • With a Return On Equity value of -1.12%, ALTRI is not doing good in the industry: 70.75% of the companies in the same industry are doing better.
  • ALTRI's Return On Invested Capital of 0.00% is on the low side compared to the rest of the industry. ALTRI is outperformed by 79.25% of its industry peers.
Industry RankSector Rank
ROA -1.02%
ROE -1.12%
ROIC 0%
ROA(3y)1.54%
ROA(5y)N/A
ROE(3y)1.72%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ALTRI.PA Yearly ROA, ROE, ROICALTRI.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2022 2023 2024 2025 0 -5 -10 -15 -20

1.3 Margins

  • ALTRI's Profit Margin has improved in the last couple of years.
  • ALTRI has a Operating Margin of 0.01%. This is amonst the worse of the industry: ALTRI underperforms 80.19% of its industry peers.
  • ALTRI's Operating Margin has improved in the last couple of years.
  • ALTRI has a better Gross Margin (62.66%) than 86.79% of its industry peers.
  • ALTRI's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 0.01%
PM (TTM) N/A
GM 62.66%
OM growth 3Y17.04%
OM growth 5YN/A
PM growth 3Y25.71%
PM growth 5YN/A
GM growth 3Y1.99%
GM growth 5Y12.3%
ALTRI.PA Yearly Profit, Operating, Gross MarginsALTRI.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2022 2023 2024 2025 0 20 -20 40 60

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

9

2. ALTRI.PA Health Analysis

2.1 Basic Checks

  • ALTRI has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
  • Compared to 1 year ago, ALTRI has about the same amount of shares outstanding.
  • ALTRI has about the same amout of shares outstanding than it did 5 years ago.
  • ALTRI has a better debt/assets ratio than last year.
ALTRI.PA Yearly Shares OutstandingALTRI.PA Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2022 2023 2024 2025 1M 2M 3M
ALTRI.PA Yearly Total Debt VS Total AssetsALTRI.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2022 2023 2024 2025 20M 40M 60M

2.2 Solvency

  • An Altman-Z score of 5.61 indicates that ALTRI is not in any danger for bankruptcy at the moment.
  • With an excellent Altman-Z score value of 5.61, ALTRI belongs to the best of the industry, outperforming 95.28% of the companies in the same industry.
  • The Debt to FCF ratio of ALTRI is 0.01, which is an excellent value as it means it would take ALTRI, only 0.01 years of fcf income to pay off all of its debts.
  • ALTRI has a better Debt to FCF ratio (0.01) than 99.06% of its industry peers.
  • A Debt/Equity ratio of 0.00 indicates that ALTRI is not too dependend on debt financing.
  • ALTRI has a better Debt to Equity ratio (0.00) than 97.17% of its industry peers.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0.01
Altman-Z 5.61
ROIC/WACC0
WACC8.04%
ALTRI.PA Yearly LT Debt VS Equity VS FCFALTRI.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2022 2023 2024 2025 0 20M 40M

2.3 Liquidity

  • ALTRI has a Current Ratio of 11.26. This indicates that ALTRI is financially healthy and has no problem in meeting its short term obligations.
  • With an excellent Current ratio value of 11.26, ALTRI belongs to the best of the industry, outperforming 100.00% of the companies in the same industry.
  • A Quick Ratio of 9.97 indicates that ALTRI has no problem at all paying its short term obligations.
  • The Quick ratio of ALTRI (9.97) is better than 100.00% of its industry peers.
Industry RankSector Rank
Current Ratio 11.26
Quick Ratio 9.97
ALTRI.PA Yearly Current Assets VS Current LiabilitesALTRI.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2022 2023 2024 2025 10M 20M 30M 40M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

0

3. ALTRI.PA Growth Analysis

3.1 Past

  • ALTRI shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -116.31%.
  • ALTRI shows a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 29.14% yearly.
  • ALTRI shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -12.41%.
  • The Revenue has been decreasing by -0.29% on average over the past years.
EPS 1Y (TTM)-116.31%
EPS 3Y29.14%
EPS 5YN/A
EPS Q2Q%-111.11%
Revenue 1Y (TTM)-12.41%
Revenue growth 3Y2.81%
Revenue growth 5Y-0.29%
Sales Q2Q%-10.72%

3.2 Future

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y-2.78%
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year5.12%
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
ALTRI.PA Yearly Revenue VS EstimatesALTRI.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 20M 40M 60M
ALTRI.PA Yearly EPS VS EstimatesALTRI.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 0 -0.5 -1

More info and screens

Find the best growth stocksShow best growing peers

2

4. ALTRI.PA Valuation Analysis

4.1 Price/Earnings Ratio

  • ALTRI reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
  • The Price/Forward Earnings ratio is 13.81, which indicates a correct valuation of ALTRI.
  • Based on the Price/Forward Earnings ratio, ALTRI is valued a bit cheaper than the industry average as 66.04% of the companies are valued more expensively.
  • Compared to an average S&P500 Price/Forward Earnings ratio of 37.39, ALTRI is valued rather cheaply.
Industry RankSector Rank
PE N/A
Fwd PE 13.81
ALTRI.PA Price Earnings VS Forward Price EarningsALTRI.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 -20 -40

4.2 Price Multiples

  • ALTRI's Price/Free Cash Flow ratio is in line with the industry average.
Industry RankSector Rank
P/FCF 17.77
EV/EBITDA -25.44
ALTRI.PA Per share dataALTRI.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4 6 8 10

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. ALTRI.PA Dividend Analysis

5.1 Amount

  • No dividends for ALTRI!.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

ALTRI.PA Fundamentals: All Metrics, Ratios and Statistics

TRILOGIQ

EPA:ALTRI (4/10/2026, 7:00:00 PM)

4.98

+0.14 (+2.89%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryMachinery
Earnings (Last)07-24
Earnings (Next)N/A
Inst Owners1.72%
Inst Owner ChangeN/A
Ins Owners76.77%
Ins Owner ChangeN/A
Market Cap18.63M
Revenue(TTM)21.90M
Net Income(TTM)-421.00K
Analysts86.67
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 13.81
P/S 0.85
P/FCF 17.77
P/OCF 14.39
P/B 0.49
P/tB 0.5
EV/EBITDA -25.44
EPS(TTM)-0.11
EYN/A
EPS(NY)0.36
Fwd EY7.24%
FCF(TTM)0.28
FCFY5.63%
OCF(TTM)0.35
OCFY6.95%
SpS5.86
BVpS10.07
TBVpS10.06
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -1.02%
ROE -1.12%
ROCE 0.01%
ROIC 0%
ROICexc 0.01%
ROICexgc 0.01%
OM 0.01%
PM (TTM) N/A
GM 62.66%
FCFM 4.79%
ROA(3y)1.54%
ROA(5y)N/A
ROE(3y)1.72%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3Y31.78%
ROICexgc growth 5YN/A
ROICexc growth 3Y31.69%
ROICexc growth 5YN/A
OM growth 3Y17.04%
OM growth 5YN/A
PM growth 3Y25.71%
PM growth 5YN/A
GM growth 3Y1.99%
GM growth 5Y12.3%
F-Score4
Asset Turnover0.53
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0.01
Debt/EBITDA 0.01
Cap/Depr 22.63%
Cap/Sales 1.12%
Interest Coverage 250
Cash Conversion 118.83%
Profit Quality N/A
Current Ratio 11.26
Quick Ratio 9.97
Altman-Z 5.61
F-Score4
WACC8.04%
ROIC/WACC0
Cap/Depr(3y)38.04%
Cap/Depr(5y)N/A
Cap/Sales(3y)1.5%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-116.31%
EPS 3Y29.14%
EPS 5YN/A
EPS Q2Q%-111.11%
EPS Next Y-2.78%
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-12.41%
Revenue growth 3Y2.81%
Revenue growth 5Y-0.29%
Sales Q2Q%-10.72%
Revenue Next Year5.12%
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-99.88%
EBIT growth 3Y20.32%
EBIT growth 5YN/A
EBIT Next Year187.5%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-58.25%
FCF growth 3YN/A
FCF growth 5Y-4.81%
OCF growth 1Y-53.62%
OCF growth 3YN/A
OCF growth 5Y-3.83%

TRILOGIQ / ALTRI.PA Fundamental Analysis FAQ

What is the ChartMill fundamental rating of TRILOGIQ (ALTRI.PA) stock?

ChartMill assigns a fundamental rating of 4 / 10 to ALTRI.PA.


Can you provide the valuation status for TRILOGIQ?

ChartMill assigns a valuation rating of 2 / 10 to TRILOGIQ (ALTRI.PA). This can be considered as Overvalued.


What is the profitability of ALTRI stock?

TRILOGIQ (ALTRI.PA) has a profitability rating of 3 / 10.


Can you provide the financial health for ALTRI stock?

The financial health rating of TRILOGIQ (ALTRI.PA) is 9 / 10.